EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Silybum marianum-Derived Compounds in Prostate Cancer: Mechanisms of Action and Translational Potential

Federica Randisi, Giulia Modoni iD, Mattia Riva iD, Gianpaolo Perletti iD, Davide Odorico, Emanuela Marras iD, Marzia Bruna Gariboldi iD

International Journal of Molecular Sciences · 20.05.2026 · 27 (10) · 4605

DOI: 10.3390/ijms27104605 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.05.2026. Verfasst von Federica Randisi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Life Sciences (DBSV), University of Insubria, 21100 Varese, Italy. Hauptthemen laut MEDLINE: Silybum marianum, Prostatic Neoplasms, Silymarin, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is the second most frequently diagnosed solid malignancy in men and a major cause of cancer-related mortality worldwide. While localized disease is associated with excellent long-term survival, advanced and castration-resistant PCa continues to represent a major therapeutic challenge. Current management ranges from active surveillance for indolent tumors to multimodal systemic approaches for metastatic disease. In this context, natural compounds are attracting increasing interest as adjunctive or novel therapeutic agents. Among these, silymarin, a Silybum marianum-derived flavonolignan complex, has shown promising antineoplastic activity in preclinical PCa models. In vitro, silymarin compounds consistently inhibit PCa cell proliferation by inducing G1 and G2/M cell cycle arrest, upregulating cyclin-dependent kinase inhibitors, and activating caspase-dependent apoptotic pathways. They also modulate key oncogenic signaling pathways involved in cell survival, proliferation, invasion, and metastasis. In vivo xenograft and transgenic models further show reduced tumor growth, angiogenesis, and metastatic spread with limited systemic toxicity. Emerging clinical evidence, including systematic reviews and meta-analyses, suggests translational potential; however, robust randomized trials are needed to define optimal formulations, dosing strategies, and therapeutic efficacy in PCa patients. This review provides a comprehensive overview of the molecular mechanisms, preclinical efficacy, and emerging clinical evidence supporting silymarin as a candidate for future PCa research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Silybum marianumProstatic NeoplasmsSilymarinAntineoplastic Agents, PhytogenicHumansMaleAnimalsCell ProliferationApoptosisSignal Transduction

Stichwörter der Autor:innen

Silybum marianumhuman studiesin vitro studiesin vivo studiesmilk thistleprostate cancersilibininsilymarin

Substanzen

SilymarinAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Biotechnology and Life Sciences (DBSV), University of Insubria, 21100 Varese, Italy.

ORCID-Profile: Giulia Modoni, Mattia Riva, Gianpaolo Perletti, Emanuela Marras, Marzia Bruna Gariboldi

Zitieren

APA

Randisi, F., Modoni, G., Riva, M., Perletti, G., Odorico, D., Marras, E., & Gariboldi, M. B. (2026). Silybum marianum-Derived Compounds in Prostate Cancer: Mechanisms of Action and Translational Potential. International Journal of Molecular Sciences, 27(10), 4605. https://doi.org/10.3390/ijms27104605

Vancouver

Randisi F, Modoni G, Riva M, Perletti G, Odorico D, Marras E, et al. Silybum marianum-Derived Compounds in Prostate Cancer: Mechanisms of Action and Translational Potential. International Journal of Molecular Sciences. 2026;27(10):4605. doi:10.3390/ijms27104605

BibTeX
@article{Randisi2026,
  author = {Randisi, Federica and Modoni, Giulia and Riva, Mattia and Perletti, Gianpaolo and Odorico, Davide and Marras, Emanuela and Gariboldi, Marzia Bruna},
  title = {Silybum marianum-Derived Compounds in Prostate Cancer: Mechanisms of Action and Translational Potential},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {10},
  pages = {4605},
  doi = {10.3390/ijms27104605}
}
Kostenlos starten →